Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Nederland
  4. Euronext Amsterdam
  5. Pharming Group N.V.
  6. Nieuws
  7. Persberichten
    PHARM   NL0010391025

PHARMING GROUP N.V.

(PHARM)
Real-time koersen. Real Time Euronext Amsterdam - 25/10 17:35:04
0.7934 EUR   -1.07%
22/10BEURSAGENDA : Nederlandse bedrijven
AM
22/10BEURSAGENDA : Nederlandse bedrijven
AM
21/10BEURSAGENDA : Nederlandse bedrijven
AM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Communiquťs de presse de la sociťtť PHARMING GROUP N.V.
22/10PHARMING N : Pharming Group Notice of 9M Results
PU
22/10PHARMING N : Group Notice of 9M Results
PU
14/09PHARMING N : Pharming announces results from clinical trials for the treatment of COVID-19..
PU
14/09PHARMING N : announces results from clinical trials for the treatment of COVID-19 with RUC..
PU
14/09PHARMING N : publiceert resultaten van klinische studies naar de behandeling van COVID-19 ..
PU
05/08PHARMING N : Group reports financial results for the first half of 2021
PU
29/07SIGN UP NOW : Pharming's Half Year Financial Results Webinar
PU
20/07PHARMING N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R..
PU
01/07PHARMING N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and..
PU
01/07ORCHARD THERAPEUTICS : and Pharming Group Announce Collaboration to Develop and Commercial..
AQ
23/06PHARMING N : Pharming announces completion of enrolment in Phase II/III study with lenioli..
PU
23/06PHARMING N : announces completion of enrolment in Phase II/III study with leniolisib for a..
PU
18/06PHARMING N : Pharming appoints Anurag Relan as Chief Medical Officer and Robert Friesen as..
PU
18/06PHARMING N : benoemt Anurag Relan tot Chief Medical Officer en Robert Friesen tot Chief Sc..
PU
18/06PHARMING N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc..
PU
04/06PHARMING N : announces the reimbursement of RUCONESTģ in Spain
PU
01/06PHARMING N : Group to present at Jefferies Virtual Healthcare Conference
PU
13/05PHARMING N : Group reports financial results for the first quarter of 2021
PU
17/03PHARMING N : Group presenteert tijdens de 31ste jaarlijkse Oppenheimer Healthcare Conferen..
PU
11/03PHARMING N : Group presenteert op BioCapital Europe 2021
PU
08/03PHARMING N : Phishing, Pharming, Malware, And Other Internet Delights
AQ
02/03PHARMING N : Group, in collaboration with Invitae Corporation, launches genetic testing pr..
PU
02/03PHARMING N : Group start, in samenwerking met Invitae Corporation, genetisch testprogramma..
PU
2020PHARMING N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR..
PU
2020PHARMING N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List..
PU
2020PHARMING N : Reports on Extraordinary General Meeting of Shareholders
PU
2020PHARMING N : announces enrolment of first patient in US clinical trial for the treatment o..
PU
2020PHARMING N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after ..
PU
2020PHARMING N : announces commitment to build a new downstream manufacturing facility for RUC..
PU
2020PHARMING N : appoints Jeroen Wakkerman as Chief Financial Officer
PU
2020PHARMING N : Group reports financial results for the first nine months of 2020
PU
2020PHARMING N : convenes Extraordinary General Meeting of shareholders
PU
2020PHARMING N : receives Orphan Drug Designation from the European Commission for leniolisib ..
PU
2020PHARMING N : announces the publication of data from a compassionate use programme of RUCON..
PU
2020PHARMING N : announces enrolment of first patient in multinational clinical trial for the ..
PU
2020PHARMING N : Group reports financial results for the first half of 2020
PU
2020PHARMING N : Seven Ways to Rob You during COVID-19
AQ
2020PHARMING N : reports encouraging results from use of RUCONESTģ in COVID-19 patients
PU
2020PHARMING N : Group convenes Annual General Meeting of shareholders
PU
2020PHARMING N : Publication of Pharming's 2019 Annual Report
PU
2020PHARMING N : CFO to step down
PU
2020PHARMING N : Group Reports Strong Preliminary (Unaudited) Financial Results for 2019
PU
2020PHARMING N : receives EMA approval of new facility for expansion of RUCONESTģ production
PU
2020PHARMING N : announces the placement of Ä125 million senior unsecured convertible bonds du..
PU
2020PHARMING N : announces the launch of an offering of approximately Ä125 million senior unse..
PU
2019PHARMING : responds to press speculation
PU
2019PHARMING : announces completion of minority investment in BioConnection BV Pharming announ..
PU
2019PHARMING : Press releaseMarch 28 Pharming Group announces publication of its Annual Report..
PU
2018PHARMING : reports favourable conclusion from first investigator-initiated direct comparat..
PU
2018PHARMING : reports interim financial results for the first nine months of 2018
PU
2018PHARMING : reports positive data from first investigator-initiated study of rhC1-Inhibitor..
PU
2018PHARMING : Receives Complete Response Letter from FDA
PU
2018PHARMING : announces further issue of shares as employee options are exercised
PU
2018PHARMING : Capital Market Briefing recording and slide deck
PU
2018PHARMING : Sign up for Pharming's Capital Markets Briefing – Webinar details inside
PU
2018PHARMING : announces Agenda for its Capital Markets Briefing to be held on 21 June 2018 in..
PU
2018PHARMING : Interim Report on Financial Results for the First Quarter 2018
PU
2018A GLOBAL AWARENESS DAY FOR A RARE LI : World HAEday, 16th May 2018
PU
2018PHARMING : announces publication of 2017 Annual Report and invitation to Annual General Me..
PU
2017PHARMING : Submits Supplemental Biologics License Application to FDA for RUCONESTģ for Pro..
PU
2017PHARMING : announces positive data from paediatric clinical trial with RUCONESTģ
PU
2017PHARMING : N.V. and HAEi International Patient Organization announce partnership with Ince..
PU
2017PHARMING : announces cashless warrant exercises and conversions of its Ordinary Bonds into..
PU
2017PHARMING : Reports on Financial Results for the First Half of 2017
PU
2017PHARMING : announces publication of RUCONESTģ prophylactic data in The Lancet
PU
2017PHARMING : announces completion of its refinancing with a single US$100 million debt facil..
PU
2017PHARMING : announces withdrawal of agenda items related to Amendment of the Articles of As..
PU
2017PHARMING : Interim Report on Financial Results for the First Quarter 2017
PU
2017PHARMING : announces refinancing of its existing debt by a single US$100 million debt faci..
PU
2017A GLOBAL AWARENESS DAY FOR A RARE LI : World HAEday, 16th May 2017
PU
2017PHARMING : Report on Preliminary Financial Results for 2016
PU
2017VAN LEEUWENHOECK ISSUES RESEARCH NOT : Turning the Page
PU
2017PHARMING : announces additional conversions of its Amortizing Bonds
PU
2017PHARMING : announces issue of new stock as a result of conversion of Amortizing Bonds
PU
2017PHARMING : announces issue of new stock as a result of conversion of Amortizing Bonds
PU
1  2Volgende
Volgende evenement op PHARMING GROUP N.V.
Komende gebeurtenissen in de sector